Kidswell Bio Corporation
TSE:4584
Kidswell Bio Corporation
Total Liabilities & Equity
Kidswell Bio Corporation
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
K
|
Kidswell Bio Corporation
TSE:4584
|
Total Liabilities & Equity
¥5.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
10%
|
GNI Group Ltd
TSE:2160
|
Total Liabilities & Equity
¥65.6B
|
CAGR 3-Years
34%
|
CAGR 5-Years
30%
|
CAGR 10-Years
26%
|
|
PeptiDream Inc
TSE:4587
|
Total Liabilities & Equity
¥69.5B
|
CAGR 3-Years
38%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Total Liabilities & Equity
¥121.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Total Liabilities & Equity
¥7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
8%
|
S
|
StemRIM Inc
TSE:4599
|
Total Liabilities & Equity
¥10.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
See Also
What is Kidswell Bio Corporation's Total Liabilities & Equity?
Total Liabilities & Equity
5.2B
JPY
Based on the financial report for Dec 31, 2023, Kidswell Bio Corporation's Total Liabilities & Equity amounts to 5.2B JPY.
What is Kidswell Bio Corporation's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
10%
Over the last year, the Total Liabilities & Equity growth was 25%. The average annual Total Liabilities & Equity growth rates for Kidswell Bio Corporation have been 12% over the past three years , 12% over the past five years , and 10% over the past ten years .